Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients
2025 · JACC Advances · 2 citations
https://doi.org/10.1016/j.jacadv.2025.101800
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
26
Citations
2
h-index
1
i10-index
Joycie Chang is an academic researcher from University of Missouri–Kansas City. The author has contributed to research in topics: Diabetes Treatment and Management & Polyomavirus and related diseases & Pancreatic and Hepatic Oncology Research. The author has an h-index of 2, co-authored 7 publications.
https://doi.org/10.1016/j.jacadv.2025.101800
https://doi.org/10.1016/j.jaad.2025.05.261
https://doi.org/10.1016/j.cson.2026.100120
Click to start Chat